tiprankstipranks
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
US Market

Entrada Therapeutics Inc (TRDA) Stock Investors

51 Followers
Based on 723,149 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold TRDA
On average, investors allocate 0.00% of their portfolios to TRDA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 723,149 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding TRDA

1.3%
Last 7
Days
14.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding TRDA, out of 723,149 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

TRDA Investor Activity

No data currently available
Based on the activity of 13,602 investors who made their portfolios public
The table shows changes in TRDA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

TRDA Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.22%
-0.16%
+1.13%
41.01B
Consumer Cyclical
Coherus Biosciences
2.68%
-0.92%
-3.42%
253.91M
Healthcare
Riot Platforms
5.08%
+0.62%
+5.27%
3.15B
Financial
Merck & Company
4.06%
+0.21%
+0.71%
317.37B
Healthcare
UiPath
3.52%
-0.89%
+3.57%
13.06B
Technology
Delta Air Lines
5.41%
+0.09%
-0.41%
29.22B
Industrials
Marathon Digital Holdings
5.68%
-0.85%
+6.82%
5.92B
Financial
Raytheon Technologies
4.09%
-0.66%
-1.15%
127.15B
Industrials
Novo Nordisk
5.55%
+1.00%
+12.27%
581.35B
Healthcare
Citigroup
5.12%
>-0.01%
+0.09%
116.50B
Financial
Based on the activity of 723,149 active portfolios
Open your Smart Portfolio

TRDA Investor Analysis

TRDA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.5%
of TRDA holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
TRDA investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
37.5%
of TRDA holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
TRDA investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
50.0%
of TRDA holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of TRDA stock investors
See who invests in TRDA according to age group and performance.

FAQ

How many retail Investors hold TRDA?
<0.1% of TipRanks' retail investors hold TRDA in their portfolios.
    What is TRDA Investor Sentiment?
    TRDA’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of TRDA in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of TRDA in the last 7 days.
        What percentage of retail investors changed their holding of TRDA in the last 30 days?
        ▲ 14.1% of TipRanks' retail investors changed their holding of TRDA in the last 30 days.
          What is the average age of retail investors who hold TRDA?
          The average age of TRDA Holders is over 55.
            What other stocks have TRDA investors also bought?
            TRDA Investors also bought DKNG, CHRS, RIOT, MRK, PATH, DAL, MARA, RTX, NVO, C.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ATECAlphatec Holdings
              CORCencora
              NOTVInotiv
              BCRXBioCryst
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis